Literature DB >> 10463363

Phenotypic variation of a new P0 mutation in genetically identical twins.

W Marques1, M G Hanna, S R Marques, M G Sweeney, P K Thomas, N W Wood.   

Abstract

We have identified a new point mutation in the myelin protein zero (P0) gene in two genetically identical twins with a demyelinating neuropathy. The G to A transition at nucleotide position 382 caused an aspartic acid to asparagine substitution in exon 3. Moreover, we found clear clinical differences which were most evident at an early age. These observations suggest that the expression of this P0 mutation may be susceptible to external, non-genetic influences that may act early in the course of the disease to alter the phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463363     DOI: 10.1007/s004150050410

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.

Authors:  Yi-Chung Lee; Bing-Wen Soong; Yo-Tsen Liu; Kon-Ping Lin; Ker-Pei Kao; Zin-An Wu
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 2.  [The role of the immune system in hereditary demyelinating neuropathies].

Authors:  M Mäurer; K V Toyka; R Martini
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis.

Authors:  D H Kilfoyle; P J Dyck; Y Wu; W J Litchy; D M Klein; P J B Dyck; N Kumar; J M Cunningham; C J Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

4.  Two novel missense mutations in the myelin protein zero gene causes Charcot-Marie-Tooth type 2 and Déjérine-Sottas syndrome.

Authors:  Geir J Braathen; Jette C Sand; Michael B Russell
Journal:  BMC Res Notes       Date:  2010-04-12

5.  Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.

Authors:  Silmara P Gouvea; Vinícius H S Borghetti; Keity C Bueno; Adriana B Genari; Charles M Lourenço; Claudia Sobreira; Amilton A Barreira; Wilson Marques
Journal:  Neurogenetics       Date:  2009-08-25       Impact factor: 2.660

6.  Factors contributing to decreased protein stability when aspartic acid residues are in beta-sheet regions.

Authors:  P R Pokkuluri; M Gu; X Cai; R Raffen; F J Stevens; M Schiffer
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

7.  Tracing myelin protein zero (P0) in vivo by construction of P0-GFP fusion proteins.

Authors:  Arif B Ekici; Sevinc Oezbey; Christina Fuchs; Eva Nelis; Christine Van Broeckhoven; Melitta Schachner; Bernd Rautenstrauss
Journal:  BMC Cell Biol       Date:  2002-11-26       Impact factor: 4.241

Review 8.  Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.

Authors:  Joana L C Cordeiro; Wilson Marques; Jaime E C Hallak; Flávia L Osório
Journal:  ASN Neuro       Date:  2014-05-27       Impact factor: 4.146

9.  Coexistent Charcot-Marie-Tooth type 1A and type 2 diabetes mellitus neuropathies in a Chinese family.

Authors:  A-Ping Sun; Lu Tang; Qin Liao; Hui Zhang; Ying-Shuang Zhang; Jun Zhang
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.